We are live on ! Find out more
MD icon

Pediatrix Medical

213 hedge funds and large institutions have $853M invested in Pediatrix Medical in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 74 increasing their positions, 83 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,550% more call options, than puts

Call options by funds: $429K | Put options by funds: $26K

10% more capital invested

Capital invested by funds: $777M → $853M (+$75.8M)

1.65% more ownership

Funds ownership: 99.46%101.12% (+1.7%)

4% less funds holding

Funds holding: 223213 (-10)

11% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 83

27% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 33

Holders
213
Holders Change
-10
Holders Change %
-4.48%
% of All Funds
3.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
74
Reduced
83
Closed
33
Calls
$429K
Puts
$26K
Net Calls
+$403K
Net Calls Change
+$169K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$136M -$466K -50,036 -0.4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$106M +$1.53M +164,333 +2%
AllianceBernstein
3
AllianceBernstein
Tennessee
$81.1M +$1.83M +197,198 +3%
Pacer Advisors
4
Pacer Advisors
Pennsylvania
$52.4M +$18.5M +1,993,086 +62%
EARNEST Partners
5
EARNEST Partners
Georgia
$48.1M -$252K -27,094 -0.6%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$40.2M -$3.72M -399,483 -9%
State Street
7
State Street
Massachusetts
$34M +$134K +14,453 +0.4%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$21.5M -$883K -94,860 -4%
Morgan Stanley
9
Morgan Stanley
New York
$18.4M -$8.49M -912,317 -33%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$18.2M +$347K +37,348 +2%
Charles Schwab
11
Charles Schwab
California
$18.1M +$1.56M +167,307 +10%
Boston Partners
12
Boston Partners
Massachusetts
$17.7M +$4.22M +453,254 +34%
SBH
13
Segall Bryant & Hamill
Illinois
$15.7M -$294K -31,569 -2%
Invesco
14
Invesco
Georgia
$12.2M +$1.87M +200,728 +20%
JP Morgan Chase
15
JP Morgan Chase
New York
$10.7M +$8.71M +935,774 +697%
AQR Capital Management
16
AQR Capital Management
Connecticut
$10.4M +$4.74M +509,981 +96%
ICM
17
Invenomic Capital Management
Massachusetts
$9.76M -$3.77M -405,102 -29%
RCMNY
18
Rubric Capital Management (New York)
New York
$9.11M +$8.45M +908,600 New
Northern Trust
19
Northern Trust
Illinois
$8.43M +$170K +18,325 +2%
Norges Bank
20
Norges Bank
Norway
$8.3M +$2.44M +262,514 +46%
ACB
21
Aristotle Capital Boston
Massachusetts
$8.03M -$219K -23,570 -3%
Citadel Advisors
22
Citadel Advisors
Florida
$7.49M -$14.3M -1,536,399 -67%
ACH
23
ArrowMark Colorado Holdings
Colorado
$7.43M +$432K +46,386 +7%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$7.32M -$113K -12,094 -2%
Allianz Asset Management
25
Allianz Asset Management
Germany
$6.93M +$1.47M +158,419 +30%

MD Hedge Fund Activity: Q1 2024 in Review

213 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2024, worth a combined $853M — up 9.8% from $777M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of MD and 24 opened new positions — a net loss of 9 holders — while 83 trimmed existing stakes and 74 added.

The largest buyer was Pacer Advisors, adding an estimated $18.5M. The largest seller was Citadel Advisors, cutting an estimated $14.3M.

  • 213 institutional investors held Pediatrix Medical (MD) as of Q1 2024, down from 223 in Q4 2023.
  • Funds reported $853M of Pediatrix Medical stock for Q1 2024, up 9.8% quarter-over-quarter.
  • 24 funds opened new Pediatrix Medical positions in Q1 2024 and 33 closed out, a net change of -9 holders.
  • The largest Pediatrix Medical buyer in Q1 2024 was Pacer Advisors, an estimated $18.5M added.
  • The largest Pediatrix Medical seller in Q1 2024 was Citadel Advisors, an estimated $14.3M sold.

Based on aggregated 13F filings for Q1 2024.